Project Grant R24AI198145
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $807K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded The University of Texas Southwestern Medical Center $249,000 on April 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to identify conserved antiviral host factors that restrict arbovirus replication across insect and mammalian hosts. The award funds development of an arbovirus rescue assay that screens viral immune evasion proteins (IEPs) encoded by mammalian viruses for their ability to sensitize...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a $2.92 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 1, 2025, through August 31, 2029. This award supports fundamental research investigating norovirus capsid dynamics and adaptive immune evasion mechanisms. The research utilizes a mouse norovirus model system to elucidate...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $2.54M to the University of Texas Medical Branch at Galveston under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 8, 2025, for a four-year project period concluding August 31, 2029. This Project Grant supports investigator-initiated biomedical research examining the relationship between desiccation tolerance in Aedes aegypti mosquitoes and their...
- The National Institute of Allergy and Infectious Diseases awarded the University of Texas Medical Branch at Galveston $294,150 on August 1, 2026, for research on defective pro-viruses and viral proteins in neuroHIV and HIV cure strategies under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research employs correlative microscopy (live-cell, confocal, and electron microscopy), mass spectrometry imaging, and spatial proteomic and mRNA analysis to detect, quantify, and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases awarded a $440,000 Project Grant on July 17, 2025, to the University of Texas Medical Branch at Galveston under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports research to characterize the role of tripartite motif (TRIM) proteins in regulating host innate immune responses against vector-borne bunyaviruses. The research utilizes Rift Valley Fever Virus and La Crosse...
- The National Institute of Allergy and Infectious Diseases awarded the University of Texas at Austin $209,499 on June 23, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to define the molecular nature and evolutionary conservation of RNA pathogen-associated molecular patterns generated during poxvirus infection. The research will identify and characterize immunostimulatory RNAs produced when cells are infected with vaccinia virus, determine how host dusp11 enzymes...
- The National Institute of Allergy and Infectious Diseases awarded The University of Texas Southwestern Medical Center $249,000 on July 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research to develop tools for marginal zone-specific gene expression manipulation in B cells. The project investigates how mature B cell subsets—follicular, marginal zone, and B-1 cells—contribute to protective immune responses in infection and pathogenic responses...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $626,423 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston (UTMB). The funding will support research to explore the dependence of arenaviruses on the metabolism of the monosaccharides D-glucose and D-mannose, with the goal of developing carbohydrate antimetabolite compounds as potential pan-arenavirus therapeutics. Specifically,...
- The National Institute of Allergy and Infectious Diseases awarded the University of Texas Medical Branch at Galveston $243,704 on September 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the molecular evolution and human pathogenic potential of Tacaribe virus. The funded research examines in vitro host range of Tacaribe virus and its prevalence in Peru, specifically determining whether viral mutations enable the virus to use the human transferrin...
- The National Institute of Allergy and Infectious Diseases awarded $596,318 to The University of Texas Southwestern Medical Center on February 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to define virulence factor functions in Salmonella enterica using minimal pathogen genomes. The research characterizes how a small network of SPI-2 type III secretion system effector proteins coordinate membrane scission of the Salmonella-containing vacuole (SCV) and...